- Home
- GLU vs COYA Comparison
GLU vs COYA Comparison
Compare GLU & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLU
- COYA
- Stock Information
- Founded
- GLU 2004
- COYA 2020
- Country
- GLU United States
- COYA United States
- Employees
- GLU N/A
- COYA N/A
- Industry
- GLU Finance/Investors Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- GLU Finance
- COYA Health Care
- Exchange
- GLU Nasdaq
- COYA Nasdaq
- Market Cap
- GLU 99.4M
- COYA 99.8M
- IPO Year
- GLU N/A
- COYA 2022
- Fundamental
- Price
- GLU $16.86
- COYA $5.68
- Analyst Decision
- GLU
- COYA Strong Buy
- Analyst Count
- GLU 0
- COYA 4
- Target Price
- GLU N/A
- COYA $17.00
- AVG Volume (30 Days)
- GLU 12.4K
- COYA 41.6K
- Earning Date
- GLU 01-01-0001
- COYA 05-13-2025
- Dividend Yield
- GLU 8.60%
- COYA N/A
- EPS Growth
- GLU N/A
- COYA N/A
- EPS
- GLU 0.62
- COYA N/A
- Revenue
- GLU N/A
- COYA $3,685,107.00
- Revenue This Year
- GLU N/A
- COYA $105.26
- Revenue Next Year
- GLU N/A
- COYA N/A
- P/E Ratio
- GLU $22.50
- COYA N/A
- Revenue Growth
- GLU N/A
- COYA N/A
- 52 Week Low
- GLU $11.61
- COYA $4.65
- 52 Week High
- GLU $15.40
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- GLU 60.50
- COYA 47.23
- Support Level
- GLU $16.66
- COYA $5.29
- Resistance Level
- GLU $17.03
- COYA $5.80
- Average True Range (ATR)
- GLU 0.30
- COYA 0.31
- MACD
- GLU -0.03
- COYA -0.01
- Stochastic Oscillator
- GLU 73.11
- COYA 46.59
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.